CCL28 mucosal expression in SARS-CoV-2-infected patients with diarrhea in relation to disease severity - 19/01/21
Doi : 10.1016/j.jinf.2020.08.042
Yan Yan 1, 2, 3, a, Xiufeng Jiang 4, a, Xu Wang 1, a, Bin Liu 1, Hui Ding 1, Mengjun Jiang 5, Zhenkun Yang 5, Yaping Dai 1, Difei Ding 1, Hui Yu 1, Shiliang Zhang 1, Jun Liu 1, Mingchao Sha 1, Chunyan Lui 1, Yuanwang Qiu 2, 3, ⁎ 
, Hongzhou Lu 6, ⁎ , Qinxue Hu 7, 8, b, ⁎
, Hongzhou Lu 6, ⁎ , Qinxue Hu 7, 8, b, ⁎ 1 Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China
2 The International Joint Research Laboratory for Infection and Immunity (China-Germany), Jiangnan University, Wuxi, China
3 Hepatology Institute of Wuxi, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China
4 Unit B11 of Lung Department, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China
5 Center of Clinical Laboratory, The People's Hospital of Wuxi, Wuxi, China
6 Shanghai Public Health Clinical Center, Fudan University, Shanghai, China
7 State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China
8 Institute for Infection and Immunity, St. George's, University of London, London, United Kingdom
⁎Corresponding author.⁎⁎Corresponding author.⁎⁎⁎Corresponding author.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Key words : COVID-19, SARS-CoV-2, diarrhea, CCL28, mucosal immunity
Le texte complet de cet article est disponible en PDF.
Plan
© 2020
The British Infection Association. Tous droits réservés.
Vol 82 - N° 1
P. e19-e21 - janvier 2021 Retour au numéro
Article précédent
- Rethinking environmental contamination and fomite transmission of SARS-CoV-2 in the healthcare
- Hajime Kanamori
- Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study
- Jean-Philippe Kevorkian, Jean-Pierre Riveline, Claire Vandiedonck, Diane Girard, Joris Galland, Florine Féron, Jean-François Gautier, Bruno Mégarbane
Bienvenue sur EM-consulte, la référence des professionnels de santé.